The role of galectins in the initiation, amplification and resolution of the inflammatory response

Tissue Antigens

Volumn 64, Issue 1, 2004, Pages 1-12

  Rubinstein, N ^a   Ilarregui, J M ^a   Toscano, M A ^a   Rabinovich, G A ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Apoptosis; Autoimmunity; Cancer; Galectin; Galectin 1; Glycoconjugates; Immunosuppression; Inflammation; Tumour immune escape

Indexed keywords

CARBOHYDRATE; CHEMOATTRACTANT; GALECTIN; TRINITROBENZENESULFONIC ACID;

ALLERGY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNITY; BACTERIAL INFECTION; BINDING AFFINITY; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELLULAR DISTRIBUTION; CHEMOTAXIS; EXTRACELLULAR MATRIX; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOCYTE ACTIVATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNITY; CARBOHYDRATE METABOLISM; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINES; GALECTINS; GRAFT VS HOST DISEASE; HUMANS; HYPERSENSITIVITY; IMMUNITY, NATURAL; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; INFLAMMATION; INFLAMMATION MEDIATORS; MODELS, IMMUNOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS);

EID: 3042742399     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00278.x     Document Type: Review

References (80)

1. Cooper DNW. Galectinomics: finding themes in complexity. Biochim Biophys Acta 2002: 1572: 209-31.
2. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. Introduction to galectins. Glycoconj J 2004: 19: 433-40.
3. Rabinovich GA. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Death Diff 1999: 6: 711-21.
4. Rabinovich GA, Baum LG, Tinari N et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response. Trends Immunol 2002: 23: 313-20.
5. Ahmed H, DU SJ, O'Leary N, Vasta GR. Biochemical and molecular characterization of galectins from zebrafish (Danio rerio): notochord-specific expression a prototype galectin during early embryogenesis. Glycobiol 2004: 14: 219-32.
6. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T cell growth and apoptosis. Proc Natl Acad Sci USA 1996: 93: 6737-42.
7. Fukumori T, Takenaka Y, Yoshii T et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 2003: 63: 8302-11.
8. Baum LG, Pang M, Perillo NL et al. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 1995: 181: 877-87.
9. Villa-Verde DM, Silva-Monteiro E, Jasiulionis MG et al. Galectin-3 modulates carbohydrate-dependent thymocyte interactions with the thymic microenvironment. Eur J Immunol 2002: 32: 1434-44.
10. Blaser C, Kaufmann M, Muller C et al. β-galactoside binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol 1998: 28: 2311-9.
11. Rabinovich GA, Ramhorst RE, Rubinstein N et al. Induction of allogeneic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Diff 2002: 9: 661-70.
12. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff M, Eberlein TJ. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001: 69: 555-64.
13. Zúñiga EI, Rabinovich GA, Iglesias MM, Gruppi A. Regulated expression of galectin-1 during B cell activation and implications for T-cell apoptosis. J Leukoc Biol 2001: 70: 73-9.
14. Acosta-Rodríguez EV, Montes CL, Motran CC et al. Galectin-3 mediates interleukin-4-induced survival and differentiation of B cells. Functional cross-talk and implications during Trypanosoma cruzi infection. J Immunol 2004: 172: 493-502.
15. Sato S, Hughes RC. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein in macrophages. J Biol Chem 1994: 269: 4424-30.
16. Rabinovich GA, Castagna LF, Landa CA, Riera CM, Sotomayor CE. Regulated expression of a 16kDa galectin-like protein in activated rat macrophages. J Leukoc Biol 1996: 59: 363-70.
17. Rabinovich GA, Iglesias MM, Modesti NM et al. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J Immunol 1998: 160: 4831-40.
18. Zuñiga EI, Gruppi A, Hirabayashi J, Kasai KI, Rabinovich GA. Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival. Infect Immun 2001: 69: 6804-12.
19. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995: 378: 736-9.
20. Rabinovich GA, Modesti NM, Castagna LF, Landa CA, Riera CM, Sotomayor CE. Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin. J Biochem 1997: 122: 365-73.
21. Perillo NL, Uittenbogaart CH, Nguyen JT, Baum LG. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 1997: 97: 1851-8.
22. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS. Developmental regulated expression and apoptotic potential of galectin-9, a beta-galactoside-binding lectin. J Clin Invest 1997: 99: 2452-61.
23. Pace KE, Lee C, Stewart PL, Baum LG. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 1999: 163: 3801-11.
24. Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J. Involvement of CD2 and CD3 in galectin-1-induced signaling in human Jurkat T cells. Glycobiology 2000: 10: 131-40.
25. Fouillit M, Joubert-Caron R, Poirier F et al. Regulation of CD45 signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology 2000: 10: 413-9.
26. Galvan M, Tsuboi S, Fukuda M, Baum LG. Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 2000: 275: 16730-7.
27. Amano M, Galvan M, He J, Baum LG. The ST6Ga1 I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation and T cell death. J Biol Chem 2003: 278: 7469-75.
28. Tsuboi S, Fukuda M. Branched O-linked oligosaccharide ectopically expressed in transgenic mice reduces primary T-cell immune responses. EMBO J 1997: 16: 6364-73.
29. He J, Baum LG. Presentation of galectin-1 by extracellular matrix triggers T-cell death. J Biol Chem 2004: 279: 4705-12.
30. - leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death. Leukemia 2002: 16: 840-5.
31. Roberts AA, Amano M, Felten C et al. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Mod Pathol 2003: 16: 543-51.
32. Dias-Baruffi M, Zhu H, Cho M, Karmakar S, McEver RP, Cummings RD. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem 2003: 278: 41282-93.
33. Hsu DK, Yang RY, Yu L et al. Targeted disruption of galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000: 156: 1073-83.
34. Matarrese P, Tinari N, Semeraro ML, Natoli C, Iacobelli S, Malorni W. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 2000: 473: 311-5.
35. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002: 277: 6852-7.
36. Kashio Y, Nakamura K, Abedin MJ et al. Galectin-9 induces apoptosis through the calcium-calpain-caspase 1 pathway. J Immunol 2003: 170: 3631-6.
37. Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 1999: 96: 11329-34.
38. Kuwabara I, Kuwabara Y, Yang RY et al. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 2002: 277: 3487-97.
39. Hadari YR, Arbel-Goren R, Levy Y et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 2000: 113: 2385-97.
40. Yang RY, Hsu DK, Yu L, Ni J, Liu F-T. Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J Biol Chem 2001: 276: 20252-60.
41. Swarte W, Mebius RE, Joziasse DH, van den Eijnden DH, Kraal G. Lymphocyte triggering via L-selectin leads to enhanced galectin-3-mediated binding to dendritic cells. Eur J Immunol 1998: 28: 2846-71.
42. Demetriou N, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001: 409: 733-9.
43. Chung CD, Patel VP, Moran M, Lewis LA, Miceli MC. Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol 2000: 165: 3722-9.
44. Gauthier L, Rossi B, Roux F, Termine E, Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci USA 2002: 99: 13014-9.
45. Abedin MJ, Kashio Y, Seki M, Nakamura K, Hirashima M. Potential roles of galectins in myeloid differentiation into three different lineages. J Leukoc Biol 2003: 73: 650-6.
46. Kuwabara I, Liu F-T. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 1996: 156: 3939-44.
47. Rabinovich GA, Ariel A, Hershkoviz R, Hirabayashi J, Kasai KI, Lider O. Specific inhibition of T-cell adhesion to extracellular matrix and pro-inflammatory cytokine secretion by human recombinant galecitn-1. Immunology 1999: 97: 100-6.
48. Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, Bergeron MG. Role of galectin-3 as an adhesion molecule for neutrophil extravasation during Streptococcal Pneumonia. J Immunol 2002: 168: 1813-22.
49. Matarrese P, Fusco O, Tinari N et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 2000: 85: 545-54.
50. Kim HR, Lin HM, Birilan H, Raz A. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 1999: 59: 4148-54.
51. Rabinovich GA, Daly G, Dreja H et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999: 190: 385-97.
52. Santucci L, Fiorucci S, Rubinstein N et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 2003: 124: 1381-94.
53. Santucci L, Fiorucci S, Cammilleri F, Servillo G, Federici B, Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 2000: 31: 399-406.
54. Baum LG, Blackall DP, Arias-Magallano S et al. Amelioration of graft versus host disease by galectin-1. Clin Immunol 2003: 109: 295-307.
55. Cortegano I, del Pozo V, Cardaba B et al. Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol 1998: 161: 385-9.
56. Sano H, Hsu DK, Yu L et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 2000: 165: 2156-64.
57. Matsumoto R, Hirashima M, Kita H, Gleich GJ. Biological activities of ecalectin: a novel eosinophil-activating factor. J Immunol 2002: 168: 1961-7.
58. Rabinovich GA, Sotomayor CE, Riera CM, Bianco I, Correa SG. Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol 2000: 30: 1331-9.
59. Sano H, Hsu DK, Apgar JR et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003: 112: 389-97.
60. Correa SG, Sotomayor CE, Aoki MP, Maldonado CA, Rabinovich GA. Opposite effects of galectin-1 on alternative metabolic pathways of L-arginin in resident, inflammatory and activated macrophages. Glycobiology 2003: 13: 119-28.
61. La M, Cao TV, Cerchiaro G et al. A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am J Pathol 2003: 163: 1505-15.
62. Colnot C, Ripoche MA, Milon G, Montagutelli X, Crocker PR, Poirier F. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology 1998: 94: 290-6.
63. Karlsson A, Follin P, Leffler H, Dahigren C. Galectin-3 activates the NADPH oxidase in exudated but not peripheral blood neutrophils. Blood 1998: 91: 3430-8.
64. Almkvist J, Dahlgren C, Leffler H, Karlsson A. Activation of the neutrophil nicotinamide adenine dinucleotide phosphatase oxidase by galectin-1. J Immunol 2002: 168: 4034-41.
65. Nishi N, Shoji H, Seki M et al. Galectin-8 modulates neutrophil function via interaction with integral alphaM. Glycobiology 2003: 13: 755-63.
66. Offner H, Celnik B, Bringman T, Casentini-Borocz D, Nedwin GE, Vanderbark A. Recombinant human β-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol 1990: 28: 177-84.
67. Harjacek M, Díaz-Cano S, Miguel M, Wolfe H, Maldonado C, Rabinovich GA. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile rheumatoid arthritis. J Rheumatol 2001: 28: 1914-22.
68. Ohshima S, Kuchen S, Seemayer CA et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 2003: 48: 2788-95.
69. Levy G, Tarrab-Hazdai R, Teichberg VI. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur J Immunol 1983: 13: 500-7.
70. Tuchiyama Y, Wada J, Zhang H et al. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int 1999: 58: 1941-52.
71. Giordanengo L, Gea S, Barbieri G, Rabinovich GA. Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this β-galactoside-binding protein in cardiac Chagas' disease. Clin Exp Immunol 2001: 124: 266-73.
72. Del Pozo V, Rojo M, Rubio ML et al. Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation. Am J Respir Crit Care Med 2002: 166: 732-7.
73. Delbrouck C, Doyen I, Belot N et al. Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration. Lab Invest 2002: 82: 147-58.
74. Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN. Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge. J Biol Chem 2002: 277: 14916-24.
75. Pelletier I, Sato S. Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope. J Biol Chem 2002: 277: 17663-70.
76. Pelletier I, Hashidate T, Urashima T et al. Specific recognition of Leishmania major poly-beta-galactosyl epitopes by galectin-9: possible implication of galectin-9 in interaction between L. major and host cells. J Biol Chem 2003: 278: 22223-30.
77. Lanteri M, Giordanengo V, Hiraoka N et al. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology 2003: 13: 909-18.
78. Van den Brüle F, Califice S, Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj J 2004: 19: 537-42.
79. Rubinstein N, Alvarez M, Zwirner NW et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor-immune privilege. Cancer Cell 2004: 5: 241-51.
80. Lahm H, André S, Hoeflich A et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 2001: 127: 375-86.